Sign in
4

Changes in Ownership

Immunocore Holdings plc Filed Acc 0001415889-24-005720

HEAD OF R&D sold 83,491 shares at an average $70.79 ($5,910,318)

  • HEAD OF R&D acquired 83,491 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Berman David M HEAD OF R&D 2024-02-26 Option exercise 10b5-1 +28,553 $17.46 $498,535 28,553 D
Berman David M HEAD OF R&D 2024-02-26 Sale 10b5-1 −26,516 $70.60 $1,872,030 2,037 D
Berman David M HEAD OF R&D 2024-02-26 Sale 10b5-1 −2,037 $71.31 $145,258 0 D
Berman David M HEAD OF R&D 2024-02-27 Option exercise 10b5-1 +54,938 $17.46 $959,217 54,938 D
Berman David M HEAD OF R&D 2024-02-27 Sale 10b5-1 −4,448 $69.45 $308,914 50,490 D
Berman David M HEAD OF R&D 2024-02-27 Sale 10b5-1 −21,152 $70.42 $1,489,524 29,338 D
Berman David M HEAD OF R&D 2024-02-27 Sale 10b5-1 −25,944 $71.32 $1,850,326 3,394 D
Berman David M HEAD OF R&D 2024-02-27 Sale 10b5-1 −3,394 $71.97 $244,266 0 D
Derivatives
Berman David M HEAD OF R&D 2024-02-26 Option exercise · Employee Share Option (Right to Buy) 10b5-1 −28,553 363,237 D
Berman David M HEAD OF R&D 2024-02-27 Option exercise · Employee Share Option (Right to Buy) 10b5-1 −54,938 308,299 D
Open-market sales · 83,491 sh · avg $70.79 · $5,910,318
Loading xslF345X05/form4-02282024_040201.xml…